Group One Trading’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62K | Sell |
162
-82
| -34% | -$1.32K | ﹤0.01% | 1764 |
|
|
2025
Q1 | $5.13K | Buy |
244
+10
| +4% | +$210 | ﹤0.01% | 1562 |
|
|
2024
Q4 | $5.82K | Sell |
234
-146
| -38% | -$3.63K | ﹤0.01% | 1619 |
|
|
2024
Q3 | $6.43K | Sell |
380
-274
| -42% | -$4.63K | ﹤0.01% | 1336 |
|
|
2024
Q2 | $18.4K | Buy |
654
+367
| +128% | +$10.3K | ﹤0.01% | 1200 |
|
|
2024
Q1 | $86K | Sell |
287
-26
| -8% | -$7.79K | ﹤0.01% | 841 |
|
|
2023
Q4 | $73.8K | Buy |
313
+29
| +10% | +$6.83K | ﹤0.01% | 984 |
|
|
2023
Q3 | $42.6K | Sell |
284
-257
| -48% | -$38.6K | ﹤0.01% | 1120 |
|
|
2023
Q2 | $94.2K | Buy |
+541
| New | +$94.2K | ﹤0.01% | 862 |
|
|
2023
Q1 | – | Sell |
-128
| Closed | -$38.9K | – | 2393 |
|
|
2022
Q4 | $38.9K | Buy |
+128
| New | +$38.9K | ﹤0.01% | 1157 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2452 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2521 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2619 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2511 |
|
|
2021
Q2 | – | Sell |
-352
| Closed | -$106K | – | 2424 |
|
|
2021
Q1 | $106K | Buy |
352
+35
| +11% | +$10.5K | ﹤0.01% | 1177 |
|
|
2020
Q4 | $119K | Sell |
317
-126
| -28% | -$47.3K | ﹤0.01% | 986 |
|
|
2020
Q3 | $136K | Buy |
+443
| New | +$136K | ﹤0.01% | 862 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1754 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1702 |
|
|
2019
Q4 | – | Sell |
-12
| Closed | -$5K | – | 1669 |
|
|
2019
Q3 | $5K | Buy |
12
+2
| +20% | +$833 | ﹤0.01% | 1159 |
|
|
2019
Q2 | $12K | Buy |
+10
| New | +$12K | ﹤0.01% | 1006 |
|
|
2018
Q3 | – | Sell |
-17
| Closed | -$27K | – | 1671 |
|
|
2018
Q2 | $27K | Buy |
17
+3
| +21% | +$4.77K | ﹤0.01% | 1014 |
|
|
2018
Q1 | $23K | Sell |
14
-55
| -80% | -$90.4K | ﹤0.01% | 1009 |
|
|
2017
Q4 | $116K | Buy |
+69
| New | +$116K | ﹤0.01% | 770 |
|